ada 2025 retatrutide results π A triple-action once-weekly injection can significantly lower blood sugar and body weight in people with type 2 diabetes, a new phase 3 trial shows. is part of an emerging generation ADA '26: Lilly's dominance, Pfizer's
Description
Microneedles offer higher efficiency and user compliance, faster delivery, and can be self-administered
The escalation schedule often follows this pattern: Week 1-4 : 0.25 mg once weekly Week 5-8 : 0.5 mg once weekly Week 9-12 : 1.0 mg once weekly Week 13-16 : 1.7 mg once weekly Week 17 and beyond : Up to 2.4 mg once weekly , which is the maximum dose for weight loss
10.1074/jbc.270.44.26488 106
In China, domestic companies are closely aligning with these global trends, and leading players are actively advancing in this direction
